Mamounas, Eleftherios P. http://orcid.org/0000-0002-9476-2553
Tang, Gong
Paik, Soonmyung
Baehner, Frederick L.
Liu, Qing
Jeong, Jong-Hyeon
Kim, S. Rim
Butler, Steven M.
Jamshidian, Farid
Cherbavaz, Diana B.
Sing, Amy P.
Shak, Steven
Julian, Thomas B.
Lembersky, Barry C.
Lawrence Wickerham, D.
Costantino, Joseph P.
Wolmark, Norman
Funding for this research was provided by:
National Institutes of Health (U10CA-180868, U10CA-180822, UG1CA-189867)
Bristol-Myers Squibb Pharmaceutical Research Institute (n/a)
Article History
Received: 16 October 2017
Accepted: 24 October 2017
First Online: 11 November 2017
Compliance with ethical standards
:
: Eleftherios P. Mamounas, MD: GHI, Genentech: Consultant, Speakers’ Bureau; Biotheranostics, GRAIL: Consultant; Roche, Celcuity, Macrogenics: Consultant. Gong Tang, PhD: Consulting from: ExxonMobil Biomedical Science Inc. Frederick L. Baehner, MD: Employee, GHI: Salary and stock. Steven M. Butler, PhD: Prior employee of GHI (Departed Dec, 2014), currently retired. Diana B. Cherbavaz, PhD: GHI Employment and equity. Amy P. Sing, MD: Former employee of GHI, stock ownership. Steven Shak, MD: GHI employee, shareholder. Soonmyung Paik, MD, Qing Liu, Jong-Hyeon Jeong, PhD, Seong-Rim Kim, MD, Farid Jamshidian, PhD, Thomas B. Julian, MD, Barry C. Lembersky, MD, D. Lawrence Wickerham, MD, Joseph P. Costantino, Dr PH, and Norman Wolmark, MD declare that they have no conflict of interest.